Research presented at ECCMID suggests unvaccinated teenagers and adults were at highest risk of developing measles, whilst the biggest threat of mortality was to those under the age of two.
Browsing: Clinical > Vaccines
A novel initiative is working to ensure that approximately 1 billion individuals are vaccinated against yellow fever across 27 African countries by 2026.
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
A proof-of-concept study has demonstrated promise for a new vaccine production platform, which was used to build a prototype synthetic flu vaccine.
Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine.
A Phase II trial has suggested potential for new Bacille Calmette–Guerin revaccination strategies in addition to hope for subunit vaccines against tuberculosis.
Listen to our podcast rounding up the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.
New research shows that all-cause mortality is lower in children whose most recent immunization was the measles vaccine.
Take a look at the top news stories of the week, including the FDA approval of HIV drug Biktarvy and the discovery of a genetic predisposition to congenital Zika syndrome.
Oral vaccines are less immunogenic when given to infants in low-income countries, compared with high-income countries, limiting their potential public health impact and in this review the authors evaluate the factors that might contribute to this phenomenon.